Tuesday , 16 July 2024

Tag Archives: cardiovascular

A Comparative Safety and Efficacy Study of Olmesrtan, a Newer Angiotensin-II Type-1 Receptor Blocker in Early Stage Type–2 Diabetes with Hypertension

Enugula Vijay Kumar*, Shaik Mohammed Yusuf, M. Vara Prsanna Rao, B. Nagendra Prasad, C. Surya Savarny Srinivasa Institute of Pharmaceutical Sciences, Proddatur, YSR Kadapa, Andhra Pradesh, India A B S T R A C T Patients with type-2 diabetes are at high risk for developing cardiovascular diseases, which are also the most common cause of death in these patients. Angiotensin II ... Read More »

Scroll To Top